Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Angiodynamics (ANGO) Restructuring Costs (2016 - 2026)

Angiodynamics' Restructuring Costs history spans 15 years, with the latest figure at $6.5 million for Q1 2026.

  • For Q1 2026, Restructuring Costs rose 98.48% year-over-year to $6.5 million; the TTM value through Feb 2026 reached $15.1 million, down 31.12%, while the annual FY2025 figure was $15.6 million, 70.63% down from the prior year.
  • Restructuring Costs reached $6.5 million in Q1 2026 per ANGO's latest filing, up from $3.6 million in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $35.4 million in Q1 2024 to a low of $2.0 million in Q2 2022.
  • Average Restructuring Costs over 5 years is $6.0 million, with a median of $3.6 million recorded in 2023.
  • Peak YoY movement for Restructuring Costs: soared 949.78% in 2024, then tumbled 90.71% in 2025.
  • A 5-year view of Restructuring Costs shows it stood at $3.1 million in 2022, then skyrocketed by 102.29% to $6.2 million in 2023, then dropped by 5.17% to $5.9 million in 2024, then plummeted by 38.05% to $3.6 million in 2025, then surged by 79.42% to $6.5 million in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Restructuring Costs are $6.5 million (Q1 2026), $3.6 million (Q4 2025), and $2.8 million (Q3 2025).